Analyst Recommendations

Wolfe Research analyst issues OUTPERFORM recommendation for TKO on March 28, 2024 07:00AM ET. The previous analyst recommendation was Outperform.TKO was trading at $86.39 at issue of the...

March 28, 2024   TKO 3.18%

Keefe, Bruyette & Woods analyst issues MARKET PERFORM recommendation for KBH on March 28, 2024 07:11AM ET. The previous analyst recommendation was Market Perform.KBH was trading at $69.56...

March 28, 2024   KBH 4.30%

William Blair analyst issues OUTPERFORM recommendation for SLDB on March 28, 2024 07:03AM ET. SLDB was trading at $14.25 at issue of the analyst recommendation.The overall analyst consensus...

March 28, 2024   SLDB 4.89%

Susquehanna analyst issues POSITIVE recommendation for CSX on March 28, 2024 07:26AM ET. The previous analyst recommendation was Positive.CSX was trading at $36.84 at issue of the analyst...

March 28, 2024   CSX 1.48%

Susquehanna analyst issues NEUTRAL recommendation for CP on March 28, 2024 07:23AM ET. The previous analyst recommendation was Neutral.CP was trading at $88.46 at issue of the analyst...

March 28, 2024   CP 2.20%

RBC Capital analyst issues OUTPERFORM recommendation for AROC on March 28, 2024 07:23AM ET. The previous analyst recommendation was Outperform.AROC was trading at $19.34 at issue of the...

March 28, 2024   AROC 2.65%

Susquehanna analyst issues NEUTRAL recommendation for UNP on March 28, 2024 07:28AM ET. The previous analyst recommendation was Neutral.UNP was trading at $244.63 at issue of the analyst...

March 28, 2024   UNP 2.06%

Susquehanna analyst issues NEUTRAL recommendation for NSC on March 28, 2024 07:27AM ET. The previous analyst recommendation was Neutral.NSC was trading at $251.72 at issue of the analyst...

March 28, 2024   NSC 2.10%

Raymond James analyst issues STRONG BUY recommendation for PSA on March 28, 2024 03:31AM ET. The previous analyst recommendation was Outperform.PSA was trading at $288.1 at issue of...

March 28, 2024   PSA 1.17%

Goldman Sachs analyst issues BUY recommendation for MRNA on March 28, 2024 05:33AM ET. The previous analyst recommendation was Buy.MRNA was trading at $110.59 at issue of the...

March 28, 2024   MRNA 2.48%